Lifecore Biomedical Inc (LFCR)
6.98
-0.50
(-6.68%)
USD |
NASDAQ |
Nov 21, 16:00
6.975
0.00 (0.00%)
Pre-Market: 20:00
Lifecore Biomedical Total Liabilities (Quarterly): 250.76M for Aug. 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2024 | 250.76M |
| May 31, 2024 | 242.64M |
| February 29, 2024 | 228.56M |
| November 30, 2023 | 244.40M |
| August 31, 2023 | 259.18M |
| May 31, 2023 | 257.78M |
| February 28, 2023 | 201.95M |
| November 30, 2022 | 204.91M |
| August 31, 2022 | 188.90M |
| May 31, 2022 | 186.88M |
| February 28, 2022 | 181.51M |
| November 30, 2021 | 265.92M |
| August 31, 2021 | 251.75M |
| May 31, 2021 | 300.14M |
| February 28, 2021 | 305.20M |
| November 30, 2020 | 290.22M |
| August 31, 2020 | 285.02M |
| May 31, 2020 | 310.27M |
| February 29, 2020 | 302.39M |
| November 30, 2019 | 300.92M |
| August 31, 2019 | 281.19M |
| May 31, 2019 | 248.95M |
| February 28, 2019 | 231.52M |
| November 30, 2018 | 158.08M |
| August 31, 2018 | 149.52M |
| Date | Value |
|---|---|
| May 31, 2018 | 152.14M |
| February 28, 2018 | 135.69M |
| November 30, 2017 | 146.60M |
| August 31, 2017 | 135.80M |
| May 31, 2017 | 130.46M |
| February 28, 2017 | 122.00M |
| November 30, 2016 | 121.79M |
| August 31, 2016 | 126.82M |
| May 31, 2016 | 130.30M |
| February 29, 2016 | 122.07M |
| November 30, 2015 | 134.43M |
| August 31, 2015 | 118.58M |
| May 31, 2015 | 126.36M |
| February 28, 2015 | 124.80M |
| November 30, 2014 | 129.99M |
| August 31, 2014 | 118.41M |
| May 31, 2014 | 108.86M |
| February 28, 2014 | 107.14M |
| November 30, 2013 | 111.99M |
| August 31, 2013 | 105.36M |
| May 31, 2013 | 110.53M |
| February 28, 2013 | 108.32M |
| November 30, 2012 | 110.35M |
| August 31, 2012 | 112.76M |
| May 31, 2012 | 126.13M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
181.51M
Minimum
Feb 2022
310.27M
Maximum
May 2020
252.96M
Average
254.76M
Median
Total Liabilities (Quarterly) Benchmarks
| AngioDynamics Inc | 97.05M |
| Precision Optics Corp Inc | 7.101M |
| Sage Therapeutics Inc | 70.60M |
| Outset Medical Inc | 245.07M |
| NovaBay Pharmaceuticals Inc | 2.805M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 246.82M |
| Shareholders Equity (Quarterly) | -3.938M |
| Debt to Equity Ratio | -32.48 |
| Current Ratio | 1.831 |
| Net Debt Paydown Yield | -3.88% |